(-)-demecolcine decreases expression ISO RGD:1349730 6480464 Demecolcine results in decreased expression of PCM1 mRNA CTD PMID:23649840 1,2-dimethylhydrazine decreases expression ISO RGD:1621600 6480464 1, 2-Dimethylhydrazine results in decreased expression of PCM1 mRNA CTD PMID:22206623 17alpha-ethynylestradiol decreases expression ISO RGD:1349730 6480464 Ethinyl Estradiol results in decreased expression of PCM1 mRNA CTD PMID:18936297 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1621600 6480464 Tetrachlorodibenzodioxin affects the expression of PCM1 mRNA CTD PMID:18691609 more ... 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of PCM1 mRNA CTD PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of PCM1 mRNA CTD PMID:34747641 2,4-dinitrotoluene affects expression EXP 6480464 2, 4-dinitrotoluene affects the expression of PCM1 mRNA CTD PMID:21346803 2,6-dinitrotoluene affects expression EXP 6480464 2, 6-dinitrotoluene affects the expression of PCM1 mRNA CTD PMID:21346803 3H-1,2-dithiole-3-thione decreases expression EXP 6480464 1, 2-dithiol-3-thione results in decreased expression of PCM1 mRNA CTD PMID:19162173 4,4'-diaminodiphenylmethane increases expression ISO RGD:1621600 6480464 4, 4'-diaminodiphenylmethane results in increased expression of PCM1 mRNA CTD PMID:18648102 aflatoxin B1 increases expression ISO RGD:1621600 6480464 Aflatoxin B1 results in increased expression of PCM1 mRNA CTD PMID:19770486 all-trans-retinoic acid decreases expression ISO RGD:1349730 6480464 Tretinoin results in decreased expression of PCM1 mRNA CTD PMID:33167477 antirheumatic drug increases expression ISO RGD:1349730 6480464 Antirheumatic Agents results in increased expression of PCM1 mRNA CTD PMID:24449571 aristolochic acid A decreases expression ISO RGD:1349730 6480464 aristolochic acid I results in decreased expression of PCM1 mRNA CTD PMID:33212167 arsenite(3-) multiple interactions ISO RGD:1349730 6480464 arsenite inhibits the reaction [G3BP1 protein binds to PCM1 mRNA] CTD PMID:32406909 arsenous acid decreases expression ISO RGD:1349730 6480464 Arsenic Trioxide results in decreased expression of PCM1 mRNA CTD PMID:22521957 arsenous acid increases response to substance ISO RGD:1349730 6480464 PCM1 protein results in increased susceptibility to Arsenic Trioxide CTD PMID:20707922 benzo[a]pyrene increases mutagenesis ISO RGD:1349730 6480464 Benzo(a)pyrene results in increased mutagenesis of PCM1 gene CTD PMID:25435355 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of PCM1 mRNA CTD PMID:25181051 , PMID:30816183 bisphenol A increases expression ISO RGD:1621600 6480464 bisphenol A results in increased expression of PCM1 mRNA CTD PMID:35598803 butanal decreases expression ISO RGD:1349730 6480464 butyraldehyde results in decreased expression of PCM1 mRNA CTD PMID:26079696 cadmium dichloride decreases expression ISO RGD:1621600 6480464 Cadmium Chloride results in decreased expression of PCM1 mRNA CTD PMID:24982889 caffeine affects phosphorylation ISO RGD:1349730 6480464 Caffeine affects the phosphorylation of PCM1 protein CTD PMID:35688186 cannabidiol increases expression ISO RGD:1349730 6480464 Cannabidiol results in increased expression of PCM1 mRNA CTD PMID:27918106 carbon nanotube decreases expression ISO RGD:1621600 6480464 Nanotubes more ... CTD PMID:25554681 cisplatin decreases phosphorylation ISO RGD:1621600 6480464 Cisplatin results in decreased phosphorylation of PCM1 protein CTD PMID:22006019 clorgyline increases expression ISO RGD:1349730 6480464 Clorgyline results in increased expression of PCM1 mRNA CTD PMID:19691856 clozapine decreases expression ISO RGD:1621600 6480464 Clozapine results in decreased expression of PCM1 mRNA CTD PMID:19048012 copper atom increases expression EXP 6480464 Copper results in increased expression of PCM1 mRNA CTD PMID:30556269 copper(0) increases expression EXP 6480464 Copper results in increased expression of PCM1 mRNA CTD PMID:30556269 copper(II) chloride decreases expression ISO RGD:1349730 6480464 cupric chloride results in decreased expression of PCM1 mRNA CTD PMID:17211630 copper(II) sulfate decreases expression ISO RGD:1349730 6480464 Copper Sulfate results in decreased expression of PCM1 mRNA CTD PMID:19549813 coumarin decreases phosphorylation ISO RGD:1349730 6480464 coumarin results in decreased phosphorylation of PCM1 protein CTD PMID:35688186 cyclosporin A decreases expression ISO RGD:1349730 6480464 Cyclosporine results in decreased expression of PCM1 mRNA CTD PMID:25562108 diarsenic trioxide increases response to substance ISO RGD:1349730 6480464 PCM1 protein results in increased susceptibility to Arsenic Trioxide CTD PMID:20707922 diarsenic trioxide decreases expression ISO RGD:1349730 6480464 Arsenic Trioxide results in decreased expression of PCM1 mRNA CTD PMID:22521957 diazinon affects expression EXP 6480464 Diazinon affects the expression of PCM1 mRNA CTD PMID:22546817 dioxygen increases expression ISO RGD:1621600 6480464 Oxygen deficiency results in increased expression of PCM1 mRNA CTD PMID:24205000 dorsomorphin multiple interactions ISO RGD:1349730 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 elemental selenium decreases expression ISO RGD:1349730 6480464 Selenium results in decreased expression of PCM1 mRNA CTD PMID:19244175 entinostat decreases expression ISO RGD:1349730 6480464 entinostat results in decreased expression of PCM1 mRNA CTD PMID:26272509 entinostat multiple interactions ISO RGD:1349730 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PCM1 mRNA CTD PMID:27188386 enzyme inhibitor multiple interactions ISO RGD:1349730 6480464 [Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of PCM1 protein CTD PMID:23301498 ethanol decreases expression EXP 6480464 Ethanol results in decreased expression of PCM1 mRNA CTD PMID:15353170 ethanol affects expression ISO RGD:1621600 6480464 Ethanol affects the expression of PCM1 mRNA CTD PMID:30319688 ethanol decreases expression ISO RGD:1621600 6480464 Ethanol results in decreased expression of PCM1 mRNA CTD PMID:29018328 flavonoids decreases expression EXP 6480464 Flavonoids results in decreased expression of PCM1 mRNA CTD PMID:18035473 folic acid decreases expression ISO RGD:1621600 6480464 Folic Acid results in decreased expression of PCM1 mRNA CTD PMID:25629700 folic acid decreases expression ISO RGD:1349730 6480464 Folic Acid results in decreased expression of PCM1 mRNA CTD PMID:21867686 geldanamycin increases expression ISO RGD:1349730 6480464 geldanamycin results in increased expression of PCM1 mRNA CTD PMID:26705709 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of PCM1 mRNA CTD PMID:22061828 hydrogen peroxide affects expression ISO RGD:1349730 6480464 Hydrogen Peroxide affects the expression of PCM1 mRNA CTD PMID:20044591 hydrogen peroxide increases expression ISO RGD:1349730 6480464 Hydrogen Peroxide results in increased expression of PCM1 mRNA CTD PMID:18951874 ivermectin decreases expression ISO RGD:1349730 6480464 Ivermectin results in decreased expression of PCM1 protein CTD PMID:32959892 josamycin affects response to substance ISO RGD:1349730 6480464 PCM1 protein affects the susceptibility to Josamycin CTD PMID:31915244 lead(0) affects splicing ISO RGD:1349730 6480464 Lead affects the splicing of PCM1 mRNA CTD PMID:28903495 lead(2+) affects splicing ISO RGD:1349730 6480464 Lead affects the splicing of PCM1 mRNA CTD PMID:28903495 lipopolysaccharide multiple interactions ISO RGD:1349730 6480464 [S-(1 more ... CTD PMID:35811015 lipopolysaccharide decreases expression ISO RGD:1349730 6480464 Lipopolysaccharides results in decreased expression of PCM1 mRNA CTD PMID:35811015 methyl methanesulfonate increases expression ISO RGD:1349730 6480464 Methyl Methanesulfonate results in increased expression of PCM1 mRNA CTD PMID:23649840 methylmercury chloride decreases expression ISO RGD:1349730 6480464 methylmercuric chloride results in decreased expression of PCM1 mRNA CTD PMID:28001369 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of PCM1 mRNA CTD PMID:25729387 panobinostat multiple interactions ISO RGD:1349730 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PCM1 mRNA CTD PMID:27188386 paracetamol affects expression ISO RGD:1621600 6480464 Acetaminophen affects the expression of PCM1 mRNA CTD PMID:17562736 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of PCM1 mRNA CTD PMID:33387578 paracetamol decreases expression ISO RGD:1349730 6480464 Acetaminophen results in decreased expression of PCM1 mRNA CTD PMID:21420995 pentanal decreases expression ISO RGD:1349730 6480464 pentanal results in decreased expression of PCM1 mRNA CTD PMID:26079696 perfluorooctane-1-sulfonic acid decreases expression ISO RGD:1349730 6480464 perfluorooctane sulfonic acid results in decreased expression of PCM1 mRNA CTD PMID:27153767 phenethyl isothiocyanate decreases expression EXP 6480464 phenethyl isothiocyanate results in decreased expression of PCM1 mRNA CTD PMID:17616710 phenylmercury acetate decreases expression ISO RGD:1349730 6480464 Phenylmercuric Acetate results in decreased expression of PCM1 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:1349730 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PCM1 mRNA CTD PMID:27188386 pirinixic acid increases expression ISO RGD:1621600 6480464 pirinixic acid results in increased expression of PCM1 mRNA CTD PMID:18445702 S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO RGD:1349730 6480464 [S-(1 more ... CTD PMID:35811015 SB 431542 multiple interactions ISO RGD:1349730 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 selenium atom decreases expression ISO RGD:1349730 6480464 Selenium results in decreased expression of PCM1 mRNA CTD PMID:19244175 silicon dioxide decreases expression ISO RGD:1621600 6480464 Silicon Dioxide results in decreased expression of PCM1 mRNA CTD PMID:19073995 sodium arsenate increases expression ISO RGD:1621600 6480464 sodium arsenate results in increased expression of PCM1 mRNA CTD PMID:21795629 sodium arsenite increases expression ISO RGD:1621600 6480464 sodium arsenite results in increased expression of PCM1 mRNA CTD PMID:32068019 succimer multiple interactions ISO RGD:1621600 6480464 [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of PCM1 mRNA CTD PMID:21641980 thapsigargin increases expression ISO RGD:1621600 6480464 Thapsigargin results in increased expression of PCM1 protein CTD PMID:24648495 thimerosal decreases expression ISO RGD:1349730 6480464 Thimerosal results in decreased expression of PCM1 mRNA CTD PMID:27188386 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of PCM1 mRNA CTD PMID:25729387 topotecan decreases expression EXP 6480464 Topotecan results in decreased expression of PCM1 mRNA CTD PMID:25729387 torcetrapib increases expression ISO RGD:1349730 6480464 torcetrapib results in increased expression of PCM1 mRNA CTD PMID:23228038 trichloroethene decreases expression EXP 6480464 Trichloroethylene results in decreased expression of PCM1 mRNA CTD PMID:33387578 trichostatin A decreases expression ISO RGD:1349730 6480464 trichostatin A results in decreased expression of PCM1 mRNA CTD PMID:24935251 , PMID:26272509 trichostatin A multiple interactions ISO RGD:1349730 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PCM1 mRNA CTD PMID:27188386 triptonide decreases expression ISO RGD:1621600 6480464 triptonide results in decreased expression of PCM1 mRNA CTD PMID:33045310 tungsten decreases expression ISO RGD:1621600 6480464 Tungsten results in decreased expression of PCM1 mRNA CTD PMID:30912803 valproic acid decreases expression ISO RGD:1349730 6480464 Valproic Acid results in decreased expression of PCM1 mRNA CTD PMID:24935251 , PMID:26272509 valproic acid multiple interactions ISO RGD:1349730 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PCM1 mRNA CTD PMID:27188386 vitamin E decreases expression ISO RGD:1349730 6480464 Vitamin E results in decreased expression of PCM1 mRNA CTD PMID:19244175 vorinostat decreases expression ISO RGD:1349730 6480464 vorinostat results in decreased expression of PCM1 mRNA CTD PMID:27188386